Athenex Announces That Two Phase 3 Pivotal Efficacy Studies of KX2-391 in Actinic Keratosis Achieved Their Primary Endpoints Read more
Innovent Receives IND Approval to Initiate Clinical Trials in China with its anti-OX40 Agonistic Antibody IBI101 and its anti-RANKL Antibody IBI307 Read more
Immunomedics Announces Clinical Collaboration With AstraZeneca in First-Line Triple-Negative Breast and Urothelial Cancers Read more
Eisai and Biogen Announce Positive Topline Results of the Final Analysis for BAN2401 at 18 Months Read more
Pivotal and APRO partner to develop 3 investigator Sponsored Trials in Genitourinary Tumors Read more
Purdue Pharma Announces Successful Completion of First-in-Human Study for Oncology Therapy Candidate Tinostamustine Read more